Collagen Peptide Market Trends: Brand Comparison, Tech Pros & Cons, and Selection Guide
Abstract: The collagen peptide market is projected to reach $9.8 billion by 2030 (CAGR 8.5%), driven by hydrolyzed Type I & III peptides. Key brands (Vital Proteins, Neocell) differ in molecular weight (2-5 kDa vs. 1-3 kDa) and solubility. Hydrolysis technology enhances bioavailability but may reduce heat stability. Selection criteria include GRAS certification, third-party purity tests (e.g., NSF), and sourcing traceability. Logistics require cold-chain control for liquid forms. Industry trends favor marine-sourced, low-allergen peptides with clinical efficacy data. This guide compares certifications (FDA, EU Novel Food), composition (glycine/proline content), and application scope (skin, joint, bone health) for informed purchasing.